Psychedelics

Psychedelics have been found to increase glutamate release and other brain proteins that lead to neuroplasticity.A multitude of research has suggested that this neuroplasticity may facilitate changes in memory, behavior and thought patterns.

The window of acute neuroplasticity can range from two days to three weeks depending on the psychedelic used. The power of the psychedelic work lies in the depth of the experience during the induction and in the post-exposure exploration, processing and application of insights that occur days, months, and years after the experience. Psychedelics have been shown to increase well-being, decrease end-of-life distress, decrease demoralization, and help treat addiction, depression and obsessive-compulsive disorder (OCD). Through neuroplastic changes, individuals with psychiatric disorders or mental health challenges can experience and develop more mental flexibility or a sense of breaking out of pathological habits.

Current research continues to investigate the advantages of utilizing psychedelics on psychiatric disorders including depression, anxiety disorders, eating disorders, OCD, bipolar disorder, chronic pain and end-of-life issues.

The mind and environment are extremely important during the use of psychedelic drugs with the patient being comfortable, relaxed, and emotionally supported. Appropriate psychotherapy during and after the drug experience can be worthwhile for integration and prolonged, sustained improvement.